|

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

RECRUITINGSponsored by Shanghai Changzheng Hospital
Actively Recruiting
SponsorShanghai Changzheng Hospital
Started2025-07-01
Est. completion2035-05-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants. The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. The 4,094 residents of Shanghai communities who have been enrolled in the STONE cohort.
2. Individuals who completed the baseline questionnaire survey, physical examination, and related clinical tests between 2016 and 2017, with complete data records.
3. Willingness to participate in this follow-up study and provision of informed consent.

Exclusion Criteria:

1. Participants who have moved away from their original community and have been living elsewhere for more than two years.
2. Participants whose contact information has changed or become invalid, resulting in loss of contact (those who remain uncontactable after three attempts to reach out).

Conditions10

Bone Metabolism DisorderCardiovascular Diseases (CVD)Cardiovascular Kidney Metabolic SyndromeChronic Kidney Disease(CKD)DiabetesDyslipidemiaHypertensionMetabolic SyndromeObesity and OverweightThyroid Diseases

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.